Alumna, Dr Darshini Ayton shares her lessons with MNHS 2020 Graduates
Congratulations everyone. This evening is an opportunity to celebrate your achievement, supported by your family and friends and your peers. We are all proud of you – you finished your studies and graduated in the year of corona.
COVID vaccination campaign: Massaging the message to appeal to Australia’s diverse population
The successful uptake of Australia's COVID program hinges on tailored communication campaigns that appeal to all sectors of the community.
PhD profile: Embracing science and technology to assess a health hazard
It was an interest in using Geospatial Information Systems (GIS) for public health purposes that drove Amanda Johnson to conduct her PhD within our Monash Centre for Occupational and Environmental Health.
Renovating your kitchen? Help Australia’s tradies avoid silicosis by not choosing artificial stone
New data shows 18% of workers in Victoria's stone benchtop industry have silicosis. Ignorance and complacency around the risks of working with artificial stone are seeing tradies paying a high price.
Young people are hungry for good sex education. There's a program in Mexico that gets it right
A sexual education program in a Mexico City school is shifting harmful beliefs and behaviours related to gender, sexuality and relationships.
For meaningful change, telehealth services need to be accessible to all
COVID-19 has fundamentally changed the way most Australians engage with healthcare, whether it be at the GP, community health centres, or in hospitals.
MIME welcomes Modern Manufacturing Initiative
The Monash Institute of Medical Engineering (MIME) welcomes the newly launched Modern Manufacturing Initiative (MMI), which forms the centrepiece of the Australian Government’s Modern Manufacturing Strategy.
Australian Breast Device Registry helps with patient safety
Almost 50,000 Australian women have had their breast devices registered, mostly in the past five years, to help facilitate faster notification of safety issues with the devices, leading to improved health outcomes.
Trial finds arthritis drugs reduce deaths and time in ICU for critical COVID-19 patients
Two arthritis treatments, the immunosuppressive drugs tocilizumab and sarilumab, have been found to have a significant impact on the survival rate of critically ill COVID-19 patients, with mortality reduced by 8.5 per cent.